Metraipolis › archive › dc_c947e53296ff

Using advanced cell models for targeted radionuclide therapy evaluation: increased efficacy in 3D versus 2D — Europe PMC PMID:41931239

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41931239
DOI
10.1186/s13550-[numero omesso]-0
License (as archived)
solo-consultazione
Archived
2026-11-03T09:25:07.879Z
SHA-256 of the archived text
f4178c67303641898c9bb0a3efda4a0f9fcec89a35fada86203d6776cc009075
Stable URL of this page
https://metraipolis.com/documento/dc_c947e53296ff

How to cite

Using advanced cell models for targeted radionuclide therapy evaluation: increased efficacy in 3D versus 2D — Europe PMC PMID:41931239 — Europe PMC (en), https://europepmc.org/article/MED/41931239 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c947e53296ff (Metraipolis archive dc_c947e53296ff, sha256 f4178c67303641898c9bb0a3efda4a0f9fcec89a35fada86203d6776cc009075)
BibTeX
@misc{dcc947e53296ff,
  title = {Using advanced cell models for targeted radionuclide therapy evaluation: increased efficacy in 3D versus 2D — Europe PMC PMID:41931239},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41931239},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c947e53296ff; sha256 f4178c67303641898c9bb0a3efda4a0f9fcec89a35fada86203d6776cc009075},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41931239. Agents can read the archived copy with the MCP tool read_document.